Amwise Diagnostic
Taipei
About Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2020)
- Website: amwisediagnostics.com
- Phone: +0800-271-271
Industries & Categories
Biotechnology, Health Care, Life Science, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/amwise-diagnostic-75264 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.